Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Dev Behav Pediatr ; 43(8): 461-464, 2022.
Article in English | MEDLINE | ID: covidwho-1985138

ABSTRACT

BACKGROUND: Decrease in sunlight exposure during periods of social distancing during the COVID-19 pandemic increased the risk of severe manifestations of vitamin D deficiency (VDD) in a particular "high-risk" population. Our objective was to highlight the importance of vitamin D screening in youth with autism spectrum disorder (ASD) and restrictive eating. CASE PRESENTATION: We describe 3 adolescent male patients with ASD who developed severe manifestations of VDD and hypocalcemia in late 2020 during the COVID-19 pandemic. All spent less time outdoors than in prior years because of isolation at home during the pandemic. Presenting symptoms included seizures and atraumatic fractures. All 3 were found to have hypocalcemia and severe VDD. Limited sun exposure because of isolation indoors during the COVID-19 pandemic was a likely contributing factor to the severity of VDD. All 3 were treated with intravenous calcium acutely, followed by oral calcium and vitamin D. Laboratory tests performed post-treatment showed biochemical resolution of hypocalcemia and VDD. CONCLUSION: These cases highlight the importance of screening "at-risk" youth for VDD. Clinicians should be cognizant that children and adolescents with ASD and restricted eating can have severe manifestations of hypocalcemia and VDD. Decreased sun exposure because of isolating indoors during the COVID-19 pandemic increased their risk for this.


Subject(s)
Autism Spectrum Disorder , COVID-19 , Hypocalcemia , Vitamin D Deficiency , Adolescent , Autism Spectrum Disorder/complications , Autism Spectrum Disorder/epidemiology , COVID-19/epidemiology , Calcium , Child , Humans , Hypocalcemia/complications , Hypocalcemia/etiology , Male , Pandemics , Vitamin D , Vitamin D Deficiency/diagnosis , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/etiology
2.
Biomed Res Int ; 2021: 6667047, 2021.
Article in English | MEDLINE | ID: covidwho-1186382

ABSTRACT

The novel coronavirus disease 2019 (COVID-19) is the cause of an acute respiratory illness which has spread around the world. The virus infects the host by binding to the angiotensin-converting enzyme 2 (ACE2) receptors. Due to the presence of ACE2 receptors in the kidneys and gastrointestinal (GI) tract, kidneys and GI tract damage arising from the virus can be seen in patients and can cause acute conditions such as acute kidney injury (AKI) and digestive problems for the patient. One of the complications of kidneys and GI involvement in COVID-19 is fluid and electrolyte disturbances. The most common ones of these disorders are hyponatremia, hypernatremia, hypokalemia, hypocalcemia, hypochloremia, hypervolemia, and hypovolemia, which if left untreated, cause many problems for patients and even increase mortality. Fluid and electrolyte disturbances are more common in hospitalized and intensive care patients. Children are also at greater risk for fluid and electrolyte disturbances complications. Therefore, clinicians should pay special attention to the fluid and electrolyte status of patients. Changes in fluid and electrolyte levels can be a good indicator of disease progression.


Subject(s)
Body Fluids/metabolism , COVID-19/etiology , Electrolytes/metabolism , Acute Kidney Injury/etiology , COVID-19/complications , Gastrointestinal Tract/physiopathology , Gastrointestinal Tract/virology , Humans , Hypocalcemia/etiology , Hypokalemia/etiology , Hyponatremia/etiology , Kidney/physiopathology , Kidney/virology
SELECTION OF CITATIONS
SEARCH DETAIL